Pharma's Almanac | Alexion Pharmaceuticals, Inc.

3 Articles Available

Investment

Rumors Suggest Amgen is Interested in Alexion

PAO-M00-19-NI-001

Acquistion

Alexion Acquires Minority Stake in Caelum Biosciences

PAO-M02-19-NI-007

FDA Approval

First Treatment for Generalized Myasthenia Gravis Approved After 60 Years

PAO-M10-17-NI-039